Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Andrx Corporation
Current Parent Company: Teva Pharmaceutical Industries
Penalty: $55,000,000
Year: 2003
Date: October 9, 2003
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: generic drug pay for delay
Mega-Scandal: Generic Drug Pay for Delay
Violation Description: Hoechst Marion Roussel and Andrx together agreed to pay $110 million to state law plaintiffs to settle their role in litigation concerning an arrangement to delay the introduction of a generic version of the heart medication Cardizem CD. Court documents did not indicate how much each would pay. Here we assume they each paid half of the total.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Michigan
Civil or Criminal Case: civil
Case ID: 2:99md1278
Case Name: In re: Cardizem CD Antitrust Litigation
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: Israel
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.